<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: prostate cancer screening</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Nearly half of all deaths from prostate cancer can be predicted before age 50</title>
   	 <description>Focusing prostate cancer testing on men at highest risk of developing the disease is likely to improve the ratio between benefits and the harms of screening, suggests a paper published today in BMJ.</description>
     <link>http://medicalxpress.com/news/2013-04-deaths-prostate-cancer-age.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 16 Apr 2013 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news285353853</guid>
	 
</item>
<item>
     <title>American College of Physicians releases new prostate cancer screening guidance statement</title>
   	 <description>Men between the ages of 50 and 69 should discuss the limited benefits and substantial harms of the prostate-specific antigen (PSA) test with their doctor before undergoing screening for prostate cancer, according to new recommendations issued today by the American College of Physicians (ACP).</description>
     <link>http://medicalxpress.com/news/2013-04-american-college-physicians-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 08 Apr 2013 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news284659031</guid>
	 
</item>
<item>
     <title>Prostate cancer risk rises in men with inherited genetic condition</title>
   	 <description>Men with an inherited genetic condition called Lynch syndrome face a higher lifetime risk of developing prostate cancer and appear to develop the disease at an earlier age, according to a new study led by researchers at the University of Michigan Comprehensive Cancer Center.</description>
     <link>http://medicalxpress.com/news/2013-04-prostate-cancer-men-inherited-genetic.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 01 Apr 2013 12:21:57 EST</pubDate>
	 <guid isPermaLink="false">news284037708</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/1-prostatecanc.jpg" width="90" height="90" />
</item>
<item>
     <title>Digital rectal exam remains important part of prostate screening</title>
   	 <description>(Medical Xpress)—The digital rectal exam is an important screening test that can discover prostate cancer that a prostate-specific antigen or PSA test may not, despite the higher sensitivity of the PSA test, according to Penn State College of Medicine researchers.</description>
     <link>http://medicalxpress.com/news/2013-03-digital-rectal-exam-important-prostate.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 18 Mar 2013 12:48:46 EST</pubDate>
	 <guid isPermaLink="false">news282829720</guid>
	 
</item>
<item>
     <title>Prostate-specific antigen screening: Values and techniques shape decisions</title>
   	 <description>What's most important to a man as he decides whether or not to undergo prostate-specific antigen- PSA- screening for prostate cancer? What does he value most about the screening? And what's the best way to present the information to help him make an appropriate decision for himself?</description>
     <link>http://medicalxpress.com/news/2013-02-prostate-specific-antigen-screening-values-techniques.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 11 Feb 2013 16:40:01 EST</pubDate>
	 <guid isPermaLink="false">news279822719</guid>
	 
</item>
<item>
     <title>Early 50s may be key time to reach baby boomers with health messages</title>
   	 <description>For baby boomers, the peak interest in health issues comes at about age 51, with a second peak coming near age 65, according to a new study.</description>
     <link>http://medicalxpress.com/news/2012-11-early-50s-key-baby-boomers.html</link>
	 <category>Health</category>
	 <pubDate>Thu, 15 Nov 2012 10:50:39 EST</pubDate>
	 <guid isPermaLink="false">news272199025</guid>
	 
</item>
<item>
     <title>Personalised prostate cancer screening may save thousands from unnecessary treatment</title>
   	 <description>Targeting prostate cancer screening based on a man's age and genes could potentially save thousands of men from unnecessary treatment and save the NHS millions of pounds. The research is presented at the NCRI Cancer Conference in Liverpool today (Monday).</description>
     <link>http://medicalxpress.com/news/2012-11-personalised-prostate-cancer-screening-thousands.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 05 Nov 2012 08:00:01 EST</pubDate>
	 <guid isPermaLink="false">news271324019</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/personalised.jpg" width="90" height="90" />
</item>
<item>
     <title>Active surveillance can reduce suffering among men with prostate cancer</title>
   	 <description>With active surveillance many men with prostate cancer could dispense with radiation treatment and surgery, and thus avoid adverse effects such as incontinence and impotence. This is the outcome of a study of almost 1,000 men diagnosed with prostate cancer conducted at Sahlgrenska Academy, University of Gothenburg, Sweden.</description>
     <link>http://medicalxpress.com/news/2012-11-surveillance-men-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 02 Nov 2012 12:10:46 EST</pubDate>
	 <guid isPermaLink="false">news271077003</guid>
	 
</item>
<item>
     <title>Advanced imaging pinpoints prostate cancer faster, more accurately</title>
   	 <description>It took Wayne Wentzel 14 years, multiple tissue biopsies and travel to four hospitals across multiple states to identify the underlying source of his rising prostate specific antigen (PSA) level. He finally found answers at the University of Cincinnati Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2012-10-advanced-imaging-prostate-cancer-faster.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 05 Oct 2012 09:21:08 EST</pubDate>
	 <guid isPermaLink="false">news268647661</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/24-clipboard-1.jpg" width="90" height="90" />
</item>
<item>
     <title>Doctors can now detect hard-to-diagnose prostate cancer</title>
   	 <description>Researchers have successfully developed and tested a new prostate cancer screening method that uses the combined power of a novel drug therapy and changes in PSA levels over time to identify men with a high PSA who are more likely to have aggressive prostate cancer despite negative biopsies.</description>
     <link>http://medicalxpress.com/news/2012-08-doctors-hard-to-diagnose-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 09 Aug 2012 00:00:01 EST</pubDate>
	 <guid isPermaLink="false">news263661779</guid>
	 
</item>
<item>
     <title>Benefits of prostate-specific antigen testing remain unclear</title>
   	 <description>(HealthDay) -- It remains unclear whether the benefits of prostate-specific antigen (PSA) testing outweigh the harms, but evidence suggests that men with a longer life expectancy may benefit from testing, according to a provisional clinical opinion from the American Society of Clinical Oncology published online July 16 in the Journal of Clinical Oncology.</description>
     <link>http://medicalxpress.com/news/2012-07-benefits-prostate-specific-antigen-unclear.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 20 Jul 2012 13:20:01 EST</pubDate>
	 <guid isPermaLink="false">news262003483</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/benefitsofpr.jpg" width="90" height="90" />
</item>
<item>
     <title>Final advice: Panel against routine prostate test</title>
   	 <description>Healthy men shouldn't get routine prostate cancer screenings, says updated advice from a government panel that found the PSA blood tests do more harm than good.</description>
     <link>http://medicalxpress.com/news/2012-05-advice-panel-routine-prostate.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 21 May 2012 18:18:52 EST</pubDate>
	 <guid isPermaLink="false">news256843126</guid>
	 
</item>
<item>
     <title>Final word: Task force recommends against PSA-based screening for prostate cancer</title>
   	 <description>Following a period for public comment, the United States Preventive Services Task Force (USPSTF) released its final recommendation for prostate cancer screening. The Task Force now recommends against PSA-based screening for all men, regardless of age. The final recommendations are being published early online in the May 22 issue of Annals of Internal Medicine, the flagship journal of the American College of Physicians (ACP).</description>
     <link>http://medicalxpress.com/news/2012-05-word-task-psa-based-screening-prostate.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 21 May 2012 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news256823670</guid>
	 
</item>
<item>
     <title>Study finds PSA testing cuts prostate cancer death risk, but does it save lives?</title>
   	 <description>(HealthDay) -- Adding another perspective to one of the most controversial and confounding issues in medicine, a new European study reports that men who received routine prostate-specific antigen (PSA) tests to check for signs of prostate cancer were 30 percent less likely to die from the disease. </description>
     <link>http://medicalxpress.com/news/2012-03-psa-prostate-cancer-death.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 14 Mar 2012 18:40:01 EST</pubDate>
	 <guid isPermaLink="false">news250968082</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/studyfindsps.jpg" width="90" height="90" />
</item>
<item>
     <title>Obesity and cancer screening: Do race and gender also play a role?</title>
   	 <description>Researchers in Family and Community Medicine at Thomas Jefferson University recently found that obesity was linked to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical cancer screening, most notably in white women. Their study on the role of obesity in cancer screening rates for prostate, cervical as well as breast and colorectal cancers across race/ethnicity and gender is examined in the current issue of the Journal of Obesity.</description>
     <link>http://medicalxpress.com/news/2012-01-obesity-cancer-screening-gender-role.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 09 Jan 2012 11:27:06 EST</pubDate>
	 <guid isPermaLink="false">news245330814</guid>
	 
</item>
<item>
     <title>Mass prostate cancer screening doesn't reduce deaths: study</title>
   	 <description>There's new evidence that annual prostate cancer screening does not reduce deaths from the disease, even among men in their 50s and 60s and those with underlying health conditions, according to new research led by Washington University School of Medicine in St. Louis.</description>
     <link>http://medicalxpress.com/news/2012-01-mass-prostate-cancer-screening-doesnt.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 06 Jan 2012 18:34:26 EST</pubDate>
	 <guid isPermaLink="false">news245097253</guid>
	 
</item>
<item>
     <title>PSA testing, combined with other relevant patient data can reduce unnecessary prostate biopsies</title>
   	 <description>Prostate cancer screening that combines an adjusted blood test with other factors including the size of the gland, the patient's overall weight and family history, can help up to one-quarter of men avoid biopsies and the risks associated with them, a Beth Israel Deaconess Medical Center-led research team says.</description>
     <link>http://medicalxpress.com/news/2011-12-psa-combined-relevant-patient-unnecessary.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 08 Dec 2011 13:04:23 EST</pubDate>
	 <guid isPermaLink="false">news242571847</guid>
	 
</item>
<item>
     <title>Cancer screening reform needed</title>
   	 <description>Since the National Cancer Institute developed the first guidelines on mammography screening over thirty years ago, advocacy and professional groups have developed guidelines focused on who should be screened, instead of communicating clearly the risks and benefits of screening, according to a commentary by Michael Edward Stefanek, Ph.D., the associate vice president of collaborative research in the office of the vice president at Indiana University, published online Nov. 21 in the Journal of the National Cancer Institute. Stefanek writes that too much time has been spent debating guidelines, instead of ongoing debates about who should be screened. He advocates educating people about the potential harms and benefits of screening.</description>
     <link>http://medicalxpress.com/news/2011-11-cancer-screening-reform.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 21 Nov 2011 16:00:02 EST</pubDate>
	 <guid isPermaLink="false">news241102027</guid>
	 
</item>
<item>
     <title>Age a big factor in prostate cancer deaths</title>
   	 <description>Contrary to common belief, men age 75 and older are diagnosed with late-stage and more aggressive prostate cancer and thus die from the disease more often than younger men, according to a University of Rochester analysis published online this week by the journal, Cancer.</description>
     <link>http://medicalxpress.com/news/2011-10-age-big-factor-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 19 Oct 2011 13:19:50 EST</pubDate>
	 <guid isPermaLink="false">news238249182</guid>
	 
</item>
<item>
     <title>Annual cancer screening tests urged less and less</title>
   	 <description>Annual cancer tests are becoming a thing of the past. New guidelines out Wednesday for cervical cancer screening have experts at odds over some things, but they are united in the view that the common practice of getting a Pap test every year is too often and probably doing more harm than good.</description>
     <link>http://medicalxpress.com/news/2011-10-annual-cancer-screening-urged.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 19 Oct 2011 04:00:01 EST</pubDate>
	 <guid isPermaLink="false">news238213870</guid>
	 
</item>
<item>
     <title>New prostate cancer screening test shows promise for diagnosis</title>
   	 <description>A new prostate screening test developed by AnalizaDx, Inc., a Cleveland-based biotech company, and studied by researchers at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center along with colleagues at the Cleveland Clinic, the Veterans Administration Boston Healthcare and the National Cancer Institute, may prove to be a promising new tool in the diagnosis of prostate cancer. The study which will be published in the September issue of Urology found that this new screening test, the PSA/SIA assay, may be more sensitive in detecting prostate cancer than traditional screening methods.</description>
     <link>http://medicalxpress.com/news/2011-08-prostate-cancer-screening-diagnosis.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 15 Aug 2011 10:57:15 EST</pubDate>
	 <guid isPermaLink="false">news232624621</guid>
	 
</item>


</channel>
</rss>
